An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX P/N Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Prothrombin complex concentrate (Primary) ; Plasma
- Indications Haemorrhage
- Focus Therapeutic Use
- Sponsors CSL Behring
- 23 May 2015 Results published in the Lancet.
- 20 Mar 2015 According to a CSL Behring media release, results from this study were published in The Lancet.
- 17 Mar 2015 Results published in a CSL Behring Media Release.